» Articles » PMID: 22615344

Long-term Outcome of Aortic Dissection with Patent False Lumen: Predictive Role of Entry Tear Size and Location

Overview
Journal Circulation
Date 2012 May 23
PMID 22615344
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patent false lumen in aortic dissection has been associated with poor prognosis. We aimed to assess the natural evolution of this condition and predictive factors.

Methods And Results: One hundred eighty-four consecutive patients, 108 surgically treated type A and 76 medically treated type B, were discharged after an acute aortic dissection with patent false lumen. Transesophageal echocardiography was performed before discharge, and computed tomography was performed at 3 months and yearly thereafter. Median follow-up was 6.42 years (quartile 1 to quartile 3: 3.31-10.49). Forty-nine patients died during follow-up (22 type A, 27 type B), 31 suddenly. Surgical or endovascular treatment was indicated in 10 type A and 25 type B cases. Survival free from sudden death and surgical-endovascular treatment was 0.90, 0.81, and 0.46 (95% CI, 0.36-0.55) at 3, 5, and 10 years, respectively. Multivariate analysis identified baseline maximum descending aorta diameter (hazard ratio [HR]: 1.32 [1.10-1.59]; P=0.003), proximal location (HR: 1.84 [1.06-3.19]; P=0.03), and entry tear size (HR: 1.13 [1.08-1.2]; P<0.001) as predictors of dissection-related adverse events, whereas mortality was predicted by baseline maximum descending aorta diameter (HR: 1.36 [1.08-1.70]; P=0.008), entry tear size (HR: 1.1 [1.04-1.16]; P=0.001), and Marfan syndrome (HR: 3.66 [1.65-8.13]; P=0.001).

Conclusions: Aortic dissection with persistent patent false lumen carries a high risk of complications. In addition to Marfan syndrome and aorta diameter, a large entry tear located in the proximal part of the dissection identifies a high-risk subgroup of patients who may benefit from earlier and more aggressive therapy.

Citing Articles

Questions and Certainty in Diagnosis and Management of Acute Type B Aortic Dissection.

Lovato L, Cocozza M, Onori A, Fattori R Rev Cardiovasc Med. 2025; 26(2):26807.

PMID: 40026512 PMC: 11868877. DOI: 10.31083/RCM26807.


Predicting Late Adverse Events in Uncomplicated Stanford Type B Aortic Dissection: Results From the ROADMAP Validation Study.

Fleischmann D, Mastrodicasa D, Willemink M, Turner V, Hinostroza V, Burris N Circ Cardiovasc Imaging. 2025; 18(2):e016766.

PMID: 39965039 PMC: 11839160. DOI: 10.1161/CIRCIMAGING.124.016766.


Transfer learning on physics-informed neural networks for tracking the hemodynamics in the evolving false lumen of dissected aorta.

Daneker M, Cai S, Qian Y, Myzelev E, Kumbhat A, Li H Nexus. 2025; 1(2).

PMID: 39949515 PMC: 11824901. DOI: 10.1016/j.ynexs.2024.100016.


Mechanisms of aortic dissection: From pathological changes to experimental and models.

Rolf-Pissarczyk M, Schussnig R, Fries T, Fleischmann D, Elefteriades J, Humphrey J Prog Mater Sci. 2025; 150.

PMID: 39830801 PMC: 11737592. DOI: 10.1016/j.pmatsci.2024.101363.


Integrated multi-omics profiling reveals neutrophil extracellular traps potentiate Aortic dissection progression.

Zhao Y, Zuo Z, Li Z, Yuan Y, Hong S, Fu W Nat Commun. 2024; 15(1):10736.

PMID: 39737994 PMC: 11686284. DOI: 10.1038/s41467-024-55038-8.